Catalyst Pharmaceuticals, Inc.
(NASDAQ : CPRX)

( )
CPRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-2.04%166.430.4%$267.67m
VRXValeant Pharmaceuticals International, Inc.
0.73%22.1914.1%$214.98m
PRGOPerrigo Co. Plc
-1.07%75.166.7%$102.77m
JAZZJazz Pharmaceuticals Plc
-1.28%164.952.2%$88.06m
PTLAPortola Pharmaceuticals, Inc.
-1.79%39.497.7%$77.19m
GWPHGW Pharmaceuticals PLC Sponsored ADR
4.22%158.227.6%$69.15m
SAGESAGE Therapeutics, Inc.
-5.17%155.899.6%$61.14m
MNKMallinckrodt Plc
1.37%16.3321.1%$57.77m
SUPNSupernus Pharmaceuticals, Inc.
0.73%54.956.3%$48.46m
PBHPrestige Brands Holdings, Inc.
1.48%33.663.8%$39.58m
UTHRUnited Therapeutics Corporation
0.46%105.5614.4%$38.61m
ICPTIntercept Pharmaceuticals, Inc.
-0.04%69.9621.8%$32.35m
CTLTCatalent Inc
-2.45%39.102.6%$31.42m
HZNPHorizon Pharma plc
1.39%15.317.5%$30.50m
ENDPEndo International Plc
7.23%6.388.9%$29.90m

Company Profile

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.